UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Allegiant Air
ALGT
$2.57B
| $219K | ﹤0.01% |
3,003
-2,475
| -45% | -$256K |
|
|
DX
2527
Dynex Capital
DX
$3.21B
| $219K | ﹤0.01% |
18,811
-2,178
| -10% | -$34K |
|
2528
Perella Weinberg Partners
PWP
$1.3B
| $218K | ﹤0.01% |
34,400
| – | – |
|
2529
Tejon Ranch
TRC
$451M
| $217K | ﹤0.01% |
15,069
-12,799
| -46% | -$203K |
|
2530
4D Molecular Therapeutics
FDMT
$562M
| $216K | ﹤0.01% |
26,894
+13,712
| +104% | +$124K |
|
2531
Energy Vault
NRGV
$633M
| $216K | ﹤0.01% |
40,874
| – | – |
|
2532
Koppers
KOP
$969M
| $214K | ﹤0.01% |
+10,291
| New | +$237K |
|
|
DMTK
2533
DELISTED
DermTech, Inc. Common Stock
DMTK
| $213K | ﹤0.01% |
53,872
+8,430
| +19% | +$51.8K |
|
|
AD
2534
Array Digital Infrastructure
AD
$3.05B
| $213K | ﹤0.01% |
8,179
+593
| +8% | +$17K |
|
|
MAGN
2535
Magnera Corp
MAGN
$460M
| $213K | ﹤0.01% |
5,263
| – | – |
|
2536
National Presto Industries
NPK
$989M
| $212K | ﹤0.01% |
3,258
| – | – |
|
2537
IDT Corp
IDT
$1.62B
| $211K | ﹤0.01% |
+8,496
| New | +$218K |
|
2538
DXP Enterprises
DXPE
$2.98B
| $211K | ﹤0.01% |
8,900
| – | – |
|
2539
Latham Group
SWIM
$880M
| $210K | ﹤0.01% |
58,540
| – | – |
|
2540
Anika Therapeutics
ANIK
$287M
| $210K | ﹤0.01% |
8,829
-1,580
| -15% | -$36.4K |
|
2541
Nomad Foods
NOMD
$1.68B
| $210K | ﹤0.01% |
+14,760
| New | +$266K |
|
|
AGTI
2542
DELISTED
Agiliti Inc
AGTI
| $209K | ﹤0.01% |
14,602
+2,702
| +23% | +$50.1K |
|
2543
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $209K | ﹤0.01% |
+7,421
| New | +$210K |
|
2544
ANI Pharmaceuticals
ANIP
$1.78B
| $208K | ﹤0.01% |
6,485
-1,638
| -20% | -$56.1K |
|
2545
Immunovant
IMVT
$8.25B
| $208K | ﹤0.01% |
37,345
-14,597
| -28% | -$71.4K |
|
2546
Forrester Research
FORR
$224M
| $208K | ﹤0.01% |
5,776
-6,461
| -53% | -$278K |
|
2547
First Mid Bancshares
FMBH
$1.36B
| $208K | ﹤0.01% |
6,503
-1,469
| -18% | -$53.2K |
|
|
WW
2548
DELISTED
WW International
WW
| $207K | ﹤0.01% |
52,633
-11,225
| -18% | -$68K |
|
|
TRUE
2549
DELISTED
TrueCar
TRUE
| $207K | ﹤0.01% |
136,907
| – | – |
|
|
EGRX
2550
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $206K | ﹤0.01% |
7,799
-5,143
| -40% | -$189K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.